• Pre Clinical And Clinical Research

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.

New Alzheimer's drug from Biogen and Eisai is just the beginning

A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.

Life science company bolsters drug discovery expertise with key appointment

ValiRx, a life science company focused on early-stage cancer therapeutics and women's health, has bolstered its drug discovery and therapeutic expertise with the appointment of Dr Cathy Tralau-Stewart as its Interim Chief Scientific Officer (CSO).

Boyds expands regulatory affairs team with experienced senior hire

Leading global drug development consultancy Boyds has added to its team with the appointment of experienced regulatory affairs professional Katherine Bowen in response to a rise in demand for its specialist regulatory services.

New startup to help pharmaceutical companies develop nanoparticle medicines

Imperial College London startup SPARTA Biodiscovery is offering technology to accelerate the development and production of nanoparticles used in advanced medicines.

Landmark partnership aims to improve Scotland’s health

A ground-breaking collaboration between NHS, university and industry partners has been launched to co-create NHS Scotland transformation through large scale programmes to improve the health of the population and expand clinical research.

Stevenage Bioscience Catalyst: First science park in the UK to adopt Warp It equipment reuse scheme

Stevenage Bioscience Catalyst is leading the way by introducing the Warp It recycling scheme. The online reuse platform will enable occupier companies to donate and receive lab and office equipment, supplies and furniture. This will reduce costs and carbon footprints for occupiers.

New study reveals first genetic links in ME and Chronic Fatigue Syndrome paving the way for new diagnostics and drugs

PrecisionLife Reports 14 Genes Associated with ME/CFS at the M.E. Genetics Research Summit in Edinburgh

BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.

BioIVT highlights ADME-Tox research advances at ISSX/MDO 2022

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, is highlighting recent ADME-Tox research at the 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX) and 24th International Symposium on Microsomes and Drug Oxidations (MDO).